Sakar Healthcare Limited (NSE:SAKAR)
India · Delayed Price · Currency is INR 920.20
-31.60 (-3.32%)
Oct 23, 2026, 1:50 PM IST
Sakar Healthcare Employees
Sakar Healthcare had 435 employees as of March 31, 2026. The number of employees increased by 93 or 27.19% compared to the previous year. That makes Sakar Healthcare the 21,181st largest employer in the world and 1,725th in India.
Employees
435
Change (1Y)
93
Growth (1Y)
27.19%
Revenue / Employee
6.25M INR
Profits / Employee
829.84K INR
Market Cap
20.47B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 435 | 93 | 27.19% |
| Mar 31, 2025 | 342 | 17 | 5.23% |
| Mar 31, 2024 | 325 | 28 | 9.43% |
| Mar 31, 2023 | 297 | 0 | - |
| Mar 31, 2022 | 297 | 50 | 20.24% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Indoco Remedies | 6,000 |
| Solara Active Pharma Sciences | 1,669 |
| Sigachi Industries | 1,400 |
| Ind-Swift Laboratories | 1,388 |
| Windlas Biotech | 1,385 |
| RPG Life Sciences | 1,366 |
| Jagsonpal Pharmaceuticals | 1,297 |
| Orchid Pharma | 1,169 |
Sakar Healthcare News
- 5 months ago - Sakar Healthcare reports 42% revenue growth in Q4FY26 - Business Upturn
- 10 months ago - Sakar Healthcare gets EMA approval to manufacture Imatinib for Accord’s European market - Business Upturn
- 11 months ago - Sakar Healthcare shares rise over 2.5% after securing nine new oncology product approvals across global markets - Business Upturn
- 11 months ago - Sakar Healthcare receives nine new marketing authorisations for Oncology products in EU and emerging markets - Business Upturn